HPV Self-sampling in the General Population
ConditionCervical Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorInternational Agency for Research on Cancer
About this trial
A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.
Eligibility criteria
Qualifiers
Women aged 30 to 65 years old
Living in the study area (Departments of Marne and Aube, France)
At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)
Disqualifiers
Outside the target age (less than 30 years old, or 66 years old and more)
Already participating in the current screening round
Total hysterectomy
History of cervical cancer
Trial design
Treatments tested in this trial
- Women receive invitation letter with HPV self-sampling kit
- Women receive invitation letter with choice of ordering a free self-sampling kit or visit healthcare provider
Treatment groups
6,000 Participants
are divided into 3 treatment groupsSponsors and collaborators
International Agency for Research on Cancer
Lead sponsor
National Cancer Institute, France
Collaborator
Central Hospital, Nancy, France
Collaborator
CHU de Reims
Collaborator
Source ClinicalTrials.gov